Expression Pathology, Flagship Partner to Offer Translational Biomarker Services

The partnership will enable tissue translational biomarker development, validation, and application to support new drug development, according to Flagship Biosciences.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.